Similarly to what was observed upon treatment with a CSF1R antagonist, prolonged depletion of T cells (via injections of anti-CD4 and anti-CD8 depleting antibodies) reduced the levels of hyperphosphorylated tau and reduced neuronal loss in the APOE4-expressing tauopathy mouse model [164, 172, 185]. This evidence concerns the gene CD8A and tauopathy.